Additionally, Xie et al. (2022) found that TK1 serves as a prognostic predictor in prostate cancer, correlating with poor outcomes, higher tumour stages, and promoting cancer progression, suggesting its potential diagnostic and therapeutic significance18. This evidence concerns the gene TK1 and Familial prostate cancer.